Skip to content
The GLP-1 Verdict
Menu

Head-to-head verdict

ShedRx vs Gala Health

Two GLP-1 providers, ruled side by side on The Verdict Score — our published six-factor rubric. Same yardstick, and no score is adjusted for payment.

WinnerGrade B+ · #4

ShedRx

Four routes to the same molecule — injection, drops, lozenges and an oral pill — plus real brand Zepbound, with health coaching bundled in.

Visit ShedRx
vs
Grade B · #7

Gala Health

A cheap compounded entry with a real brand-Ozempic path and nationwide coverage — but the $179 is a yearly-subscription rate, and Gala publishes no month-to-month price at all, which is what the verdict now docks it hardest for.

Visit Gala Health

The verdict

Winner: ShedRx

ShedRx takes it with a higher Verdict Score — 87/100 to 86/100 (grade B+ vs B). People who want options rather than one route: a needle-free form, a brand pathway, or coaching included instead of sold separately. Gala Health still earns its place — patients in any state willing to commit to a year up front for a low compounded tirzepatide rate, while keeping a legitimate brand-name option on the table.

Neither of these is our overall #1. That title goes to CoreAge Rx (94/100) — the most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.

Factor by factor

Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.

86Real-world results85
86Price honesty87
83Prescriber access88
90Formulary choice88
88Cancellation fairness84
88Member support84

Price, coverage & features

MetricShedRxGala Health
Verdict Score87/10086/100
GradeB+B
Semaglutide$199/moNot disclosed
Tirzepatide$299/mo$179/mo (annual)
CoverageAll 50 statesAll 50 states
Brand-name accessYesYes
Oral / sublingualYesNo

ShedRx

What we like

  • Four routes to a GLP-1 — injection, liquid drops, lozenges and an oral daily pill — plus brand Zepbound and Wegovy
  • Tirzepatide $299/mo month-to-month falling to $239 on a twelve-month plan; semaglutide $199 falling to $159
  • Health coaching included with membership rather than upsold
  • Publishes a 120-day weight-loss guarantee, which almost nothing else here offers

The caveats

  • The advertised "as low as $239" tirzepatide rate requires committing to twelve months — month-to-month is $299
  • Compounded medication is not FDA-approved the way brand Ozempic, Wegovy, or Zepbound are
  • The dispensing compounding pharmacy is not publicly named

Gala Health

What we like

  • Low compounded entry at $179/mo — on a yearly subscription — with all doses included, so titrating up costs nothing extra
  • Available in all 50 states, so access never blocks the sign-up
  • Offers a real FDA-approved brand path (Ozempic) alongside the compounded track, which most compounded-only programs cannot
  • Adjacent HRT and menopause care for patients who want more than a GLP-1 alone

The caveats

  • The $179 requires a yearly subscription — no month-to-month rate is published, and the cheapest term quoted in prose is $199/mo on a 3-month plan
  • The $149 'microdose' tier is sub-therapeutic — a longevity protocol, not a cheaper weight-loss dose
  • GLP-1 is compounded, not FDA-approved — the standard verification caveat applies
  • Brand Ozempic runs $1,299/mo, and the dispensing pharmacy is never named — vet it yourself

Our pick — visit

People who want options rather than one route: a needle-free form, a brand pathway, or coaching included instead of sold separately.

Visit ShedRx Read the full ShedRx review →

Also worth a look

Patients in any state willing to commit to a year up front for a low compounded tirzepatide rate, while keeping a legitimate brand-name option on the table.

Visit Gala Health Read the full Gala Health review →

Keep comparing

Neither of these has to be the answer: the rivals we rank against ShedRx cover the 7 programs closest to it, and the same shortlist for Gala Health does the reverse.

Or browse the full comparison hub and the complete rankings.

Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.